267 related articles for article (PubMed ID: 9731056)
21. Megakaryocytopoiesis in vitro: from the stem cells' perspective.
Cardier JE; Foster DC; Lok S; Jacobsen SE; Murphy MJ
Stem Cells; 1996; 14 Suppl 1():163-72. PubMed ID: 11012217
[TBL] [Abstract][Full Text] [Related]
22. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.
Drexler HG; Quentmeier H
Leukemia; 1996 Sep; 10(9):1405-21. PubMed ID: 8751457
[TBL] [Abstract][Full Text] [Related]
23. Human platelets display high-affinity receptors for thrombopoietin.
Broudy VC; Lin NL; Sabath DF; Papayannopoulou T; Kaushansky K
Blood; 1997 Mar; 89(6):1896-904. PubMed ID: 9058709
[TBL] [Abstract][Full Text] [Related]
24. Thrombopoietin stimulates VEGF release from c-Mpl-expressing cell lines and haematopoietic progenitors.
Bobik R; Hong Y; Breier G; Martin JF; Erusalimsky JD
FEBS Lett; 1998 Feb; 423(1):10-4. PubMed ID: 9506832
[TBL] [Abstract][Full Text] [Related]
25. Proliferative properties of human umbilical cord blood megakaryocyte progenitor cells to human thrombopoietin.
Hagiwara T; Kodama I; Horie K; Kato T; Miyazaki H
Exp Hematol; 1998 Mar; 26(3):228-35. PubMed ID: 9502619
[TBL] [Abstract][Full Text] [Related]
26. The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets.
Debili N; Wendling F; Cosman D; Titeux M; Florindo C; Dusanter-Fourt I; Schooley K; Methia N; Charon M; Nador R
Blood; 1995 Jan; 85(2):391-401. PubMed ID: 7529061
[TBL] [Abstract][Full Text] [Related]
27. Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation.
Alexander WS; Roberts AW; Maurer AB; Nicola NA; Dunn AR; Metcalf D
Stem Cells; 1996; 14 Suppl 1():124-32. PubMed ID: 11012212
[TBL] [Abstract][Full Text] [Related]
28. Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice.
Carver-Moore K; Broxmeyer HE; Luoh SM; Cooper S; Peng J; Burstein SA; Moore MW; de Sauvage FJ
Blood; 1996 Aug; 88(3):803-8. PubMed ID: 8704234
[TBL] [Abstract][Full Text] [Related]
29. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors.
Debili N; Wendling F; Katz A; Guichard J; Breton-Gorius J; Hunt P; Vainchenker W
Blood; 1995 Oct; 86(7):2516-25. PubMed ID: 7545460
[TBL] [Abstract][Full Text] [Related]
30. Stromal cell-derived factor-1 (SDF-1) acts together with thrombopoietin to enhance the development of megakaryocytic progenitor cells (CFU-MK).
Hodohara K; Fujii N; Yamamoto N; Kaushansky K
Blood; 2000 Feb; 95(3):769-75. PubMed ID: 10648384
[TBL] [Abstract][Full Text] [Related]
31. Effects of recombinant thrombopoietin on the growth of murine primitive and committed hematopoietic progenitors in serum-free culture.
Sasaki H; Ikuta K; Funabiki T; Fujioka K; Matsuda M
Pediatr Int; 1999 Dec; 41(6):666-72. PubMed ID: 10618888
[TBL] [Abstract][Full Text] [Related]
32. Thrombocytopenia in c-mpl-deficient mice.
Gurney AL; Carver-Moore K; de Sauvage FJ; Moore MW
Science; 1994 Sep; 265(5177):1445-7. PubMed ID: 8073287
[TBL] [Abstract][Full Text] [Related]
33. Ectopic overexpression of c-mpl by retroviral-mediated gene transfer suppressed megakaryopoiesis but enhanced erythropoiesis in mice.
Yan XQ; Lacey DL; Saris C; Mu S; Hill D; Hawley RG; Fletcher FA
Exp Hematol; 1999 Sep; 27(9):1409-17. PubMed ID: 10480432
[TBL] [Abstract][Full Text] [Related]
34. Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis.
Methia N; Louache F; Vainchenker W; Wendling F
Blood; 1993 Sep; 82(5):1395-401. PubMed ID: 7689867
[TBL] [Abstract][Full Text] [Related]
35. Existence of a differentiation blockage at the stage of a megakaryocyte precursor in the thrombocytopenia and absent radii (TAR) syndrome.
Letestu R; Vitrat N; Massé A; Le Couedic JP; Lazar V; Rameau P; Wendling F; Vuillier J; Boutard P; Plouvier E; Plasse M; Favier R; Vainchenker W; Debili N
Blood; 2000 Mar; 95(5):1633-41. PubMed ID: 10688818
[TBL] [Abstract][Full Text] [Related]
36. c-mpl, the thrombopoietin receptor.
Vainchenker W; Methia N; Debili N; Titeux M; Wendling F
Thromb Haemost; 1995 Jul; 74(1):526-8. PubMed ID: 8578519
[TBL] [Abstract][Full Text] [Related]
37. Use of human leukemia-lymphoma cell lines in hematological research: effects of thrombopoietin on human leukemia cell lines.
Drexler HG; Quentmeier H
Hum Cell; 1996 Dec; 9(4):309-16. PubMed ID: 9183663
[TBL] [Abstract][Full Text] [Related]
38. Regulation of megakaryocytopoiesis in an in vitro stroma model: preferential adhesion of megakaryocytic progenitors and subsequent inhibition of maturation.
Zweegman S; Veenhof MA; Huijgens PC; Schuurhuis GJ; Dräger AM
Exp Hematol; 2000 Apr; 28(4):401-10. PubMed ID: 10781898
[TBL] [Abstract][Full Text] [Related]
39. Megakaryocyte progenitors derived from bone marrow or G-CSF-mobilized peripheral blood CD34 cells show a distinct phenotype and responsiveness to interleukin-3 (IL-3) and PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF).
Catani L; Gugliotta L; Campanini E; Mangianti S; Gibellini D; Baravelli S; Vianelli N; Lemoli RM; Tura S
Br J Haematol; 1998 Jan; 100(1):207-18. PubMed ID: 9450813
[TBL] [Abstract][Full Text] [Related]
40. Simultaneous measurement of serum thrombopoietin and expression of megakaryocyte c-Mpl with clinical and laboratory correlates for myelofibrosis with myeloid metaplasia.
Elliot MA; Yoon SY; Kao P; Li CY; Tefferi A
Eur J Haematol; 2002 Mar; 68(3):175-9. PubMed ID: 12068799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
